Clinical Trials Directory

Trials / Completed

CompletedNCT06013436

AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal Nerve Density in Patients With SS Dry Eye

Autologous Serum Tears Combined With 0.05% Cyclosporin Eye Drop Improve Corneal Nerve Density in Patients With Sjögren's Syndrome Dry Eye

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Chengdu University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The objective of the present study was to evaluate the efficacy of autologous serum tears combined with 0.05% cyclosporin eye drop in treating Sjögren's syndrome dry eye and their effect on corneal nerves. We assessed the impact of 12-week AST combined with 0.05% cyclosporin eye drop treatment on signs, symptoms, and sub-basal nerve density (SND) in patients with dry eyes related to Sjogren's syndrome.

Detailed description

Objective: To describe the clinical efficacy and safety of the treatment of Sjögren's syndrome dry eye using autologous serum tears combined with 0.05% cyclosporin eye drop and to evaluate their effect on corneal nerves. Design: Singal-center, prospective, observational study. Patients and methods: Thirty eyes of fifteen patients with dry eye related to Sjögren syndrome were enrolled in this study. Following a 4-week washout period, the treatment was inverted for each patient for the same duration and treatment. Ocular Surface Disease Index (OSDI), tear film, break-up time, corneal staining with the use of fluorescein, Schirmer's test and corneal confocal microscopy were investigated.

Conditions

Interventions

TypeNameDescription
DRUGAutologous serum tears combined with 0.05% cyclosporin eye dropAll patients administrated autologous serum tears twelve times daily(per hour) and 0.05% cyclosporin eye drop twice times daily in each eye for 12 weeks.

Timeline

Start date
2022-06-01
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2023-08-28
Last updated
2023-08-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06013436. Inclusion in this directory is not an endorsement.